Navigation Links
DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
Date:11/16/2009

EDEN PRAIRIE, Minn., Nov. 16 /PRNewswire/ -- Announced on November 06, 2009 by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, and Mr. Christian Sedlatschek, CFO, the companies are entering a long-term partnership for the production of pharmaceutical lactose in the United States.

DAVISCO Foods is an international cheese and food ingredient company, founded in 1943, headquartered in Le Sueur, MN., a privately-held, family-owned business. DAVISCO is a company committed to technical advancement, customer service, and the production of superior quality products.

The holding group MEGGLE AG, whose headquarters are in Wasserburg, Germany was founded in 1887 and bundles the activities of the different companies within the milk and whey-processing business group. This structure embodies flexibility and decisiveness on the one hand and the traditional character of the dairy with its long history of milk-processing on the other. The Business Group Excipients & Technology is considered the leading producer of pharmaceutical lactose and excels in particular in offering High - Tech, innovative excipients to the pharmaceutical industry worldwide.

DAVISCO will expand their existing lactose production at the Le Sueur facility to accommodate additional production lines for the production of pharmaceutical lactose utilizing state-of-the-art processing technology.

MEGGLE will provide the technical marketing, sales and distribution for the pharmaceutical lactose products.

"DAVISCO Foods Intl. Inc. is excited and honored to engage in a joint venture with the MEGGLE Company to produce pharmaceutical lactose products. We have had a close and rewarding relationship for years with MEGGLE and have respected and admired their many achievements. The joint venture will produce the same high quality products and provide the same service that MEGGLE has historically produced and provided." Mr. Mark Davis, President DAVISCO Food International Inc.

"MEGGLE highly appreciates the partnership with DAVISCO. This is an important step in our strategy to expand our capacities and at the same time to offer our customers worldwide the security of a second production site." Drs Sil H. van der Ploeg, CEO of MEGGLE

www.DAVISCOFoods.com

www.MEGGLE.com

SOURCE DAVISCO Foods International, Inc.


'/>"/>
SOURCE DAVISCO Foods International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Soyfoods Do Not Impact Sperm Count
2. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
3. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
4. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
5. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
6. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
9. WellTek/MedX Group Completes Major Reorganization
10. Hill-Rom and Encompass Group Form Joint Venture
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  Twist Bioscience, a ... synthesis, today announced that it raised an additional $33 ... of $166 million. "It is an ... expand our reach and continue to deliver industry-leading gene ... market segments," commented Emily M. Leproust, Ph.D., CEO of ...
(Date:3/27/2017)... 2017 Cota Healthcare, the leading ... medicine, today announced the signing of a ... to help improve clinical and cost outcomes ... part of this agreement, which expands significantly ... January 2016, teams from across Novartis Pharmaceuticals ...
(Date:3/27/2017)...   Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company ... the Company,s Chief Operating Officer, is scheduled to present a corporate ... 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 ... ... 24th Annual Future Leaders in Biotech Industry – Friday, April 7, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... ... A study by the founder of the Buckingham Center for Facial ... recently published in the American Journal of Cosmetic Surgery. “The Effects of an Antistick ... on the use of Electro Lube during the facelift procedure. The journal, a publication ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the New England Journal of Medicine and NEJM Journal Watch, announces the release ... Review was created by a panel of pediatricians from leading medical centers. The ...
(Date:3/27/2017)... Cranbury, NJ (PRWEB) , ... March 27, 2017 ... ... publication of cutting-edge news, research and conference coverage on veterinary medicine, announces the ... The inaugural issue will be packaged with the April edition of American Veterinarian™. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Advantexe ... announced the launch of a new research study, The Business Readiness Report. The ... execute that strategy, and the actual success of achieving individual and company goals. ...
(Date:3/27/2017)... ... 2017 , ... The Association of Healthcare and Value Analysis ... first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will provide the Keynote ... analysis professionals have a ‘seat at the table’ with clinical committees when it ...
Breaking Medicine News(10 mins):